Related Experiment Video

Updated: Aug 25, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

528

STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors

Maciej Golus1, Piotr Bugajski2, Joanna Chorbińska1

  • 1Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, 50-556 Wroclaw, Poland.

Cells
|October 14, 2022
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) is crucial in cancer development. Inhibiting STAT3 effectively halts tumor growth and spread without harming normal cells, making it a promising cancer therapy target.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • Understanding tumor cell pathophysiology relies on molecular research.
  • Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor in cellular signaling.
  • Abnormal STAT3 activation is linked to cancer development, including metastasis and angiogenesis.

Purpose of the Study:

  • To investigate the role of STAT3 in cancer.
  • To evaluate STAT3 as a potential therapeutic target for neoplasms.

Main Methods:

  • Review of molecular research on STAT3.
  • Analysis of STAT3's function in cytokine-activated gene expression.
  • Assessment of STAT3's impact on tumor cell proliferation, invasion, migration, and angiogenesis.

Main Results:

  • STAT3 plays a significant role in transducing signals from the cell membrane to the nucleus.
  • Prolonged STAT3 activation promotes tumorigenesis, metastasis, proliferation, invasion, migration, and angiogenesis.
  • Inhibition of STAT3 effectively suppresses these cancer-promoting effects.

Conclusions:

  • STAT3 is a critical factor in cancer progression.
  • Targeting STAT3 offers a potential therapeutic strategy for cancer treatment.
  • STAT3 inhibition demonstrates selectivity, sparing normal cells from adverse effects.
Keywords:
STAT3bladder cancerpenile cancerprostate cancerrenal cell carcinomatesticular cancerupper tract urothelial carcinoma

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K
Three-Dimensional 3D Tumor Spheroid Invasion Assay12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

57.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K